Eric Wooltorton. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » CanadaDose-Response Relationship, DrugFluorobenzenes/administration & dosageFluorobenzenes/adverse effectsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHyperlipidemias/drug therapyPyrimidines/administration & dosagePyrimidines/adverse effectsRhabdomyolysis/chemically inducedRhabdomyolysis/physiopathologyRosuvastatin CalciumSulfonamides/administration & dosageSulfonamides/adverse effects
Substances: See more » FluorobenzenesHydroxymethylglutaryl-CoA Reductase InhibitorsPyrimidinesSulfonamidesRosuvastatin Calcium
Year: 2004 PMID: 15262879 PMCID: PMC450358 DOI: 10.1503/cmaj.1041051
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262